These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35707784)

  • 1. Genotype-Phenotype Correlations for Putative Haploinsufficient Genes in Deletions of 6q26-q27: Report of Eight Patients and Review of Literature.
    Xie X; Chai H; DiAdamo A; Grommisch B; Wen J; Zhang H; Li P
    Glob Med Genet; 2022 Jun; 9(2):166-174. PubMed ID: 35707784
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effects of 6q26-q27 Terminal Deletion on Intellectual Disability & Brain Malformations and the Genotype/Phenotype Relationship: A Case Report.
    Özdağ V; Tanir Y
    Noro Psikiyatr Ars; 2022; 59(3):242-245. PubMed ID: 36160077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental Coordination Disorder in a Patient with Mental Disability and a Mild Phenotype Carrying Terminal 6q26-qter Deletion.
    De Cinque M; Palumbo O; Mazzucco E; Simone A; Palumbo P; Ciavatta R; Maria G; Ferese R; Gambardella S; Angiolillo A; Carella M; Garofalo S
    Front Genet; 2017; 8():206. PubMed ID: 29270193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotypic spectrum of terminal 6q deletions based on a large cohort derived from social media and literature: a prominent role for DLL1.
    Engwerda A; Kerstjens-Frederikse WS; Corsten-Janssen N; Dijkhuizen T; van Ravenswaaij-Arts CMA
    Orphanet J Rare Dis; 2023 Mar; 18(1):59. PubMed ID: 36935482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern.
    Wolff DJ; Gustashaw KM; Zurcher V; Ko L; White W; Weiss L; Van Dyke DL; Schwartz S; Willard HF
    Hum Genet; 1997 Aug; 100(2):256-61. PubMed ID: 9254860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic detection of a familial 382 Kb 6q27 deletion in a fetus with isolated severe ventriculomegaly and her affected mother.
    Thakur M; Bronshtein E; Hankerd M; Adekola H; Puder K; Gonik B; Ebrahim S
    Am J Med Genet A; 2018 Sep; 176(9):1985-1990. PubMed ID: 30194807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series.
    Lesieur-Sebellin M; Till M; Khau Van Kien P; Herve B; Bourgon N; Dupont C; Tabet AC; Barrois M; Coussement A; Loeuillet L; Mousty E; Ea V; El Assal A; Mary L; Jaillard S; Beneteau C; Le Vaillant C; Coutton C; Devillard F; Goumy C; Delabaere A; Redon S; Laurent Y; Lamouroux A; Massardier J; Turleau C; Sanlaville D; Cantagrel V; Sonigo P; Vialard F; Salomon LJ; Malan V
    Prenat Diagn; 2022 Jan; 42(1):118-135. PubMed ID: 34894355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types.
    Hauptschein RS; Gamberi B; Rao PH; Frigeri F; Scotto L; Venkatraj VS; Gaidano G; Rutner T; Edwards YH; Chaganti RS; Dalla-Favera R
    Genomics; 1998 Jun; 50(2):170-86. PubMed ID: 9653644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of candidate genes responsible for structural brain abnormalities in patients with terminal deletions of chromosome 6q27.
    Peddibhotla S; Nagamani SC; Erez A; Hunter JV; Holder JL; Carlin ME; Bader PI; Perras HM; Allanson JE; Newman L; Simpson G; Immken L; Powell E; Mohanty A; Kang SH; Stankiewicz P; Bacino CA; Bi W; Patel A; Cheung SW
    Eur J Hum Genet; 2015 Jan; 23(1):54-60. PubMed ID: 24736736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo Subtelomeric 6p25.3 Deletion with Duplication of 6q23.3-q27: Genotype-Phenotype Correlation.
    Atli EI; Gurkan H; Atli E; Vatansever U; Acunas B; Mail C
    J Pediatr Genet; 2020 Mar; 9(1):32-39. PubMed ID: 31976141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial 6q microdeletion syndrome and epilepsy: a new patient and review of the literature.
    Vignoli A; Scornavacca GF; Peron A; La Briola F; Canevini MP
    Am J Med Genet A; 2013 Aug; 161A(8):2009-15. PubMed ID: 23794236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of the gene Quaking (QKI) is associated with the 6q terminal deletion syndrome.
    Backx L; Fryns JP; Marcelis C; Devriendt K; Vermeesch J; Van Esch H
    Am J Med Genet A; 2010 Feb; 152A(2):319-26. PubMed ID: 20082458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 239-kb Microdeletion Spanning
    Kosma K; Varvagiannis K; Mitrakos A; Tsipi M; Traeger-Synodinos J; Tzetis M
    Mol Syndromol; 2021 Aug; 12(5):321-326. PubMed ID: 34602960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation variable genotype/phenotype correlations of 6q27 terminal deletion derived from dic(6;18)(q27;p10).
    Zhou L; Chen C; Li H; Chen Y; Xu X; Lin X; Tang S
    Mol Cytogenet; 2014; 7(1):78. PubMed ID: 25426168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization.
    Zhang X; Snijders A; Segraves R; Zhang X; Niebuhr A; Albertson D; Yang H; Gray J; Niebuhr E; Bolund L; Pinkel D
    Am J Hum Genet; 2005 Feb; 76(2):312-26. PubMed ID: 15635506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlation in interstitial 6q deletions: a report of 12 new cases.
    Rosenfeld JA; Amrom D; Andermann E; Andermann F; Veilleux M; Curry C; Fisher J; Deputy S; Aylsworth AS; Powell CM; Manickam K; Heese B; Maisenbacher M; Stevens C; Ellison JW; Upton S; Moeschler J; Torres-Martinez W; Stevens A; Marion R; Pereira EM; Babcock M; Morrow B; Sahoo T; Lamb AN; Ballif BC; Paciorkowski AR; Shaffer LG
    Neurogenetics; 2012 Feb; 13(1):31-47. PubMed ID: 22218741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN.
    Williams ES; Barrett MJ; Dhamija R; Toran L; Chambers C; Mahadevan MS; Golden WL
    Mol Genet Genomic Med; 2018 May; 6(3):457-462. PubMed ID: 29577677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype relationship in a child with 2.3 Mb de novo interstitial 12p13.33-p13.32 deletion.
    Fanizza I; Bertuzzo S; Beri S; Scalera E; Massagli A; Sali ME; Giorda R; Bonaglia MC
    Eur J Med Genet; 2014 Jul; 57(7):334-8. PubMed ID: 24780630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region.
    Kellogg G; Sum J; Wallerstein R
    Am J Med Genet A; 2013 Jun; 161A(6):1405-8. PubMed ID: 23613140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated 6q terminal deletions: an emerging new syndrome.
    Bertini V; De Vito G; Costa R; Simi P; Valetto A
    Am J Med Genet A; 2006 Jan; 140(1):74-81. PubMed ID: 16329114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.